Applied DNA Sciences, Inc. - Common Stock (NQ:APDN)

5.620 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Applied DNA Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 30, 2024

Via Benzinga

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

October 30, 2024

Via ACCESSWIRE

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

October 15, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 01, 2024

Via Benzinga

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

September 17, 2024

Via ACCESSWIRE

Looking Into Applied DNA Sciences's Recent Short Interest ↗

September 10, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 30, 2024

Via Benzinga

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

September 18, 2024

Via ACCESSWIRE

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

September 17, 2024

Via ACCESSWIRE

Why Applied DNA Sciences (APDN) Stock Is Skyrocketing ↗

September 11, 2024

Applied DNA Sciences has expanded its mpox testing services. Shares rose 37% after the announcement.

Via Benzinga

Applied DNA Launches Mpox Clade I and Clade II Testing Service

September 11, 2024

Via ACCESSWIRE

Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

September 04, 2024

Via ACCESSWIRE

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

August 23, 2024

Via ACCESSWIRE

Looking Into Applied DNA Sciences's Recent Short Interest ↗

August 21, 2024

Via Benzinga

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 03, 2024

Via Benzinga

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank? ↗

September 03, 2024

A look at the top 20 most-searched tickers on Benzinga Pro for the month of August.

Via Benzinga

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

August 08, 2024

Via ACCESSWIRE

Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday? ↗

August 23, 2024

Applied DNA Sciences stock surges as it seeks approval to expand its mpox virus test to cover additional clades. The company awaits a decision from NYSDOH following its validation package submission,...

Via Benzinga

Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

August 21, 2024

Via Benzinga

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 19, 2024

Via Benzinga

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

August 19, 2024

Via ACCESSWIRE

Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results ↗

August 19, 2024

Via Benzinga

Topics Stocks

Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

August 19, 2024

Via Benzinga

APDN Stock Earnings: Applied DNA Sciences Reported Results for Q3 2024 ↗

August 09, 2024

Applied DNA Sciences just reported results for the third quarter of 2024.

Via InvestorPlace

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

August 07, 2024

Via ACCESSWIRE

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

July 29, 2024

Via ACCESSWIRE

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

July 29, 2024

Via ACCESSWIRE

Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability

July 25, 2024

Via ACCESSWIRE

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract

July 18, 2024

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.